• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏膜黑色素瘤:一种罕见疾病及文献综述

Mucosal Melanoma: A Rare Entity and Review of the Literature.

作者信息

Sohal Raman J, Sohal Sandeep, Wazir Ali, Benjamin Sam

机构信息

Internal Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse, USA.

Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.

出版信息

Cureus. 2020 Jul 30;12(7):e9483. doi: 10.7759/cureus.9483.

DOI:10.7759/cureus.9483
PMID:32766017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398721/
Abstract

Mucosal melanoma is a rare variant of melanoma representing around 1% of total cases of melanoma diagnosed. The usual sites of mucosal involvement are the sino-nasal passages, the oral cavity, and less commonly the upper gastrointestinal (GI) tract. It also has been reported to occur in vulvovaginal and anorectal mucosa.  We present a rare case of mucosal melanoma that presented as recurrent epistaxis, headache, and sinus pressure. CT maxillofacial imaging revealed a large mass right nasal cavity. This was biopsied by ENT and shown to be mucosal melanoma. This was treated with palliative radiation followed by immunotherapy with nivolumab.  Along with details of the case, we also discuss current treatment options with a focus on the role of immunotherapy and its efficacy in cases of head and neck mucosal melanoma. Our review of literature supports use of combination immunotherapy (including both nivolumab and ipilimumab) as it shows greater efficacy than either therapy alone. When combined with radiation therapy (RT) the overall response rate is improved and RT induces an abscopal effect; where benefits of RT are also seen at nonirradiated locations.  In our patient, the use of radiation was essentially palliative as the patient was deemed to not be a surgical candidate. We discuss in our literature review the optimum timing of radiation in relation to definitive surgery or immunotherapy.

摘要

黏膜黑色素瘤是黑色素瘤的一种罕见变体,约占确诊黑色素瘤病例总数的1%。黏膜受累的常见部位是鼻窦通道、口腔,较少见的是上消化道。据报道,它也发生在外阴阴道和肛管直肠黏膜。我们报告一例罕见的黏膜黑色素瘤病例,表现为反复鼻出血、头痛和鼻窦压痛。CT颌面成像显示右侧鼻腔有一个大肿块。耳鼻喉科对其进行了活检,结果显示为黏膜黑色素瘤。该病例先接受了姑息性放疗,随后使用纳武单抗进行免疫治疗。除了该病例的详细情况外,我们还讨论了当前的治疗选择,重点是免疫治疗的作用及其在头颈部黏膜黑色素瘤病例中的疗效。我们的文献综述支持使用联合免疫治疗(包括纳武单抗和伊匹单抗),因为它比单独使用任何一种治疗方法都更有效。当与放射治疗(RT)联合使用时,总体缓解率会提高,并且放射治疗会产生远隔效应;即在未接受照射的部位也能看到放射治疗的益处。在我们的患者中,由于患者被认为不适合手术,放射治疗本质上是姑息性的。我们在文献综述中讨论了放射治疗相对于确定性手术或免疫治疗的最佳时机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/4737a3c093b4/cureus-0012-00000009483-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/5310b6f36a98/cureus-0012-00000009483-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/7081e5464d13/cureus-0012-00000009483-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/4737a3c093b4/cureus-0012-00000009483-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/5310b6f36a98/cureus-0012-00000009483-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/7081e5464d13/cureus-0012-00000009483-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b39/7398721/4737a3c093b4/cureus-0012-00000009483-i03.jpg

相似文献

1
Mucosal Melanoma: A Rare Entity and Review of the Literature.黏膜黑色素瘤:一种罕见疾病及文献综述
Cureus. 2020 Jul 30;12(7):e9483. doi: 10.7759/cureus.9483.
2
Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.当前高级鼻腔鼻窦黏膜黑色素瘤的概念:单机构经验。
Eur Arch Otorhinolaryngol. 2019 Aug;276(8):2259-2265. doi: 10.1007/s00405-019-05458-w. Epub 2019 May 16.
3
Sinonasal mucosal melanoma: A 44-case study and literature analysis.鼻窦黏膜黑色素瘤:一项44例病例研究及文献分析。
Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Sep;134(4):237-242. doi: 10.1016/j.anorl.2017.02.003. Epub 2017 Apr 22.
4
Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.鼻腔鼻窦黏膜黑色素瘤晚期患者接受检查点抑制剂免疫治疗后出现假性进展伴随后完全缓解和严重血小板减少症。
Anticancer Drugs. 2018 Oct;29(9):914-918. doi: 10.1097/CAD.0000000000000664.
5
Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expression.纳武利尤单抗治疗失败后,伊匹木单抗对一例肿瘤突变负荷中等且程序性死亡受体配体1(PD-L1)表达阴性的肛管黑色素瘤的长期疗效。
Mol Clin Oncol. 2020 Aug;13(2):175-178. doi: 10.3892/mco.2020.2048. Epub 2020 May 21.
6
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.纳武利尤单抗单药或联合伊匹木单抗治疗黏膜黑色素瘤患者的疗效和安全性:一项汇总分析
J Clin Oncol. 2017 Jan 10;35(2):226-235. doi: 10.1200/JCO.2016.67.9258. Epub 2016 Nov 7.
7
Amelanotic Malignant Mucosal Melanoma of the Nasal Cavity: Case Report and Literature Review.鼻腔无色素性恶性黏膜黑色素瘤:病例报告及文献综述
Cureus. 2022 Feb 21;14(2):e22442. doi: 10.7759/cureus.22442. eCollection 2022 Feb.
8
Immunotherapy in mucosal melanoma: a case report and review of the literature.黏膜黑色素瘤的免疫治疗:一例病例报告及文献综述
Oncotarget. 2018 Apr 3;9(25):17971-17977. doi: 10.18632/oncotarget.24727.
9
Recurrent amelanotic melanoma of nasal cavity: Biological variability and unpredictable behavior of mucosal melanoma. A case report.鼻腔复发性无色素性黑色素瘤:黏膜黑色素瘤的生物学变异性及不可预测的行为。病例报告。
Clin Pract. 2019 Jun 11;9(2):1157. doi: 10.4081/cp.2019.1157. eCollection 2019 May 6.
10
Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.头颈部原发性黏膜黑色素瘤。口腔和鼻腔黑色素瘤的临床表现和组织病理学特征比较。
Oral Oncol. 2008 Nov;44(11):1039-46. doi: 10.1016/j.oraloncology.2008.01.014. Epub 2008 Apr 8.

引用本文的文献

1
Comparison of Prognostic Factors for Merkel Cell Carcinoma, Mucosal Melanoma and Cutaneous Malignant Melanoma: Insights into Their Etiologies. Merkel 细胞癌、黏膜黑色素瘤和皮肤恶性黑色素瘤的预后因素比较:对其病因学的深入了解。
Curr Oncol. 2023 Mar 31;30(4):3974-3988. doi: 10.3390/curroncol30040301.
2
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?转移性癌症中的远隔效应:是否有可能采用预测性方法来改善个体治疗结果?
J Clin Med. 2021 Oct 31;10(21):5124. doi: 10.3390/jcm10215124.
3
Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review.

本文引用的文献

1
Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab.一名转移性肛管黏膜黑色素瘤患者,在接受纳武单抗治疗出现寡进展后,对原发肿瘤部位进行放射治疗后获得完全且持久的缓解。
Adv Radiat Oncol. 2020 Mar 3;5(3):503-510. doi: 10.1016/j.adro.2020.02.006. eCollection 2020 May-Jun.
2
Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma.鼻窦黏膜黑色素瘤的当代多学科管理
Onco Targets Ther. 2020 Mar 16;13:2289-2298. doi: 10.2147/OTT.S182580. eCollection 2020.
3
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.
放疗对黑素瘤局部和全身控制的免疫刺激作用:综述。
Int J Mol Sci. 2020 Dec 7;21(23):9324. doi: 10.3390/ijms21239324.
纳武利尤单抗、伊匹单抗联合放疗治疗晚期黑色素瘤的前瞻性 1 期临床试验。
Clin Cancer Res. 2020 Jul 1;26(13):3193-3201. doi: 10.1158/1078-0432.CCR-19-3936. Epub 2020 Mar 23.
4
An updated review of mucosal melanoma: Survival meta-analysis.黏膜黑色素瘤的最新综述:生存情况的荟萃分析。
Mol Clin Oncol. 2019 Aug;11(2):116-126. doi: 10.3892/mco.2019.1870. Epub 2019 May 29.
5
Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases.免疫治疗时代放疗的远隔效应:已报道病例的系统评价
Cureus. 2019 Feb 20;11(2):e4103. doi: 10.7759/cureus.4103.
6
Combatting mucosal melanoma: recent advances and future perspectives.对抗黏膜黑色素瘤:最新进展与未来展望
Melanoma Manag. 2018 Oct 8;5(3):MMT11. doi: 10.2217/mmt-2018-0003. eCollection 2018 Sep.
7
Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma.纳武利尤单抗联合放疗治疗颅外转移性恶性黑色素瘤。
Jpn J Radiol. 2018 Dec;36(12):712-718. doi: 10.1007/s11604-018-0774-8. Epub 2018 Sep 11.
8
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.放射治疗与免疫检查点阻断用于黑色素瘤:一种有待进一步研究的有前景的联合策略。
Cancer J. 2017 Jan/Feb;23(1):32-39. doi: 10.1097/PPO.0000000000000236.
9
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.纳武利尤单抗单药或联合伊匹木单抗治疗黏膜黑色素瘤患者的疗效和安全性:一项汇总分析
J Clin Oncol. 2017 Jan 10;35(2):226-235. doi: 10.1200/JCO.2016.67.9258. Epub 2016 Nov 7.
10
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.纳武利尤单抗与伊匹木单抗联合用药或单药治疗初治黑色素瘤
N Engl J Med. 2015 Jul 2;373(1):23-34. doi: 10.1056/NEJMoa1504030. Epub 2015 May 31.